DK1641791T3 - 3- (guanidinocarbonyl) heterocyclic derivatives, manufacturing process and intermediates of this process, their use as drugs and pharmaceutical compositions including these - Google Patents
3- (guanidinocarbonyl) heterocyclic derivatives, manufacturing process and intermediates of this process, their use as drugs and pharmaceutical compositions including theseInfo
- Publication number
- DK1641791T3 DK1641791T3 DK04739421T DK04739421T DK1641791T3 DK 1641791 T3 DK1641791 T3 DK 1641791T3 DK 04739421 T DK04739421 T DK 04739421T DK 04739421 T DK04739421 T DK 04739421T DK 1641791 T3 DK1641791 T3 DK 1641791T3
- Authority
- DK
- Denmark
- Prior art keywords
- guanidinocarbonyl
- intermediates
- drugs
- pharmaceutical compositions
- compositions including
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0307080A FR2856062B1 (en) | 2003-06-12 | 2003-06-12 | 3-GUANIDINOCARBONYL-HETEROCYCLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME |
PCT/EP2004/005764 WO2004111048A1 (en) | 2003-06-12 | 2004-05-28 | 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1641791T3 true DK1641791T3 (en) | 2009-11-16 |
Family
ID=33484382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04739421T DK1641791T3 (en) | 2003-06-12 | 2004-05-28 | 3- (guanidinocarbonyl) heterocyclic derivatives, manufacturing process and intermediates of this process, their use as drugs and pharmaceutical compositions including these |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1641791B1 (en) |
JP (1) | JP2006527220A (en) |
AR (1) | AR044661A1 (en) |
AT (1) | ATE437877T1 (en) |
AU (1) | AU2004247350B2 (en) |
BR (1) | BRPI0411343A (en) |
CA (1) | CA2528382A1 (en) |
CL (1) | CL2004001458A1 (en) |
DE (1) | DE602004022299D1 (en) |
DK (1) | DK1641791T3 (en) |
ES (1) | ES2330524T3 (en) |
FR (1) | FR2856062B1 (en) |
IL (1) | IL172435A0 (en) |
MX (1) | MXPA05012970A (en) |
MY (1) | MY138896A (en) |
PE (1) | PE20050228A1 (en) |
PT (1) | PT1641791E (en) |
TW (1) | TW200524926A (en) |
UY (1) | UY28358A1 (en) |
WO (1) | WO2004111048A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007010572A (en) * | 2005-03-01 | 2007-10-04 | Wyeth Corp | Cinnoline compounds and their use as liver x receptor modilators. |
WO2008024977A2 (en) * | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Isoquinoline, quinazoline and phthalazine derivatives |
JP2011148751A (en) * | 2010-01-25 | 2011-08-04 | Konica Minolta Holdings Inc | Method for producing nitrogen-containing fused heterocyclic compound |
CN102603740B (en) * | 2012-03-01 | 2014-05-14 | 南京药石药物研发有限公司 | Synthetic method of 4-nitro-7-azaindole |
CN105218546B (en) * | 2015-11-04 | 2017-05-17 | 上海泰坦科技股份有限公司 | Synthesis process of 1H-pyrrolo[2,3-B] pyridine-3-carboxylic methyl ether |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2121391A1 (en) * | 1993-04-28 | 1994-10-29 | Atsuyuki Kojima | Indoloylguanidine derivatives |
JP3162572B2 (en) * | 1993-04-28 | 2001-05-08 | 住友製薬株式会社 | Indoloylguanidine derivative |
EP0639573A1 (en) * | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it |
JPH08208602A (en) * | 1994-10-18 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | Indoloylguanidine derivative |
CA2160600A1 (en) * | 1994-10-18 | 1996-04-19 | Masahumi Kitano | Indoloylguanidine derivatives |
JPH09278767A (en) * | 1996-02-15 | 1997-10-28 | Fujisawa Pharmaceut Co Ltd | Novel guanidine derivative |
DE19622222A1 (en) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Use of sodium=proton exchange inhibitor |
US6258829B1 (en) * | 1997-03-06 | 2001-07-10 | Toa Eiyo Ltd. | Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same |
-
2003
- 2003-06-12 FR FR0307080A patent/FR2856062B1/en not_active Expired - Fee Related
-
2004
- 2004-05-28 AU AU2004247350A patent/AU2004247350B2/en not_active Ceased
- 2004-05-28 CA CA002528382A patent/CA2528382A1/en not_active Abandoned
- 2004-05-28 ES ES04739421T patent/ES2330524T3/en active Active
- 2004-05-28 PT PT04739421T patent/PT1641791E/en unknown
- 2004-05-28 DK DK04739421T patent/DK1641791T3/en active
- 2004-05-28 JP JP2006515801A patent/JP2006527220A/en active Pending
- 2004-05-28 MX MXPA05012970A patent/MXPA05012970A/en active IP Right Grant
- 2004-05-28 WO PCT/EP2004/005764 patent/WO2004111048A1/en active Application Filing
- 2004-05-28 AT AT04739421T patent/ATE437877T1/en not_active IP Right Cessation
- 2004-05-28 EP EP04739421A patent/EP1641791B1/en not_active Not-in-force
- 2004-05-28 DE DE602004022299T patent/DE602004022299D1/en active Active
- 2004-05-28 BR BRPI0411343-8A patent/BRPI0411343A/en not_active IP Right Cessation
- 2004-06-10 MY MYPI20042239A patent/MY138896A/en unknown
- 2004-06-10 TW TW093116612A patent/TW200524926A/en unknown
- 2004-06-10 AR ARP040102011A patent/AR044661A1/en not_active Application Discontinuation
- 2004-06-11 CL CL200401458A patent/CL2004001458A1/en unknown
- 2004-06-11 UY UY28358A patent/UY28358A1/en unknown
- 2004-06-11 PE PE2004000583A patent/PE20050228A1/en not_active Application Discontinuation
-
2005
- 2005-12-07 IL IL172435A patent/IL172435A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004247350A1 (en) | 2004-12-23 |
TW200524926A (en) | 2005-08-01 |
MXPA05012970A (en) | 2006-05-25 |
EP1641791A1 (en) | 2006-04-05 |
BRPI0411343A (en) | 2006-07-11 |
FR2856062B1 (en) | 2005-11-11 |
UY28358A1 (en) | 2004-12-31 |
JP2006527220A (en) | 2006-11-30 |
AR044661A1 (en) | 2005-09-21 |
AU2004247350B2 (en) | 2009-07-23 |
CA2528382A1 (en) | 2004-12-23 |
PE20050228A1 (en) | 2005-05-17 |
MY138896A (en) | 2009-08-28 |
PT1641791E (en) | 2009-09-29 |
EP1641791B1 (en) | 2009-07-29 |
ATE437877T1 (en) | 2009-08-15 |
FR2856062A1 (en) | 2004-12-17 |
IL172435A0 (en) | 2006-04-10 |
WO2004111048A1 (en) | 2004-12-23 |
ES2330524T3 (en) | 2009-12-11 |
CL2004001458A1 (en) | 2005-05-20 |
DE602004022299D1 (en) | 2009-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054876D0 (en) | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds | |
DK1471057T3 (en) | Pyrimidinylacetic acid derivatives suitable for the treatment of diseases mediated by CRTH2 | |
CY2017048I1 (en) | NEW PHARMACEUTICAL USES OF STAVROSPORINE DERIVATIVES | |
NO20054220D0 (en) | Substituted N-aryl heterocycles, process for their preparation and their use as a drug | |
DK1756049T3 (en) | Process for Preparation of 1,4-Diphenylazetidinone Derivatives | |
DK1523488T3 (en) | Novel Thiophenglycoside Derivatives, Methods for their Preparation, Drugs Containing These Compounds and Their Use | |
NO20054329D0 (en) | Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them | |
DK1730131T3 (en) | Glucopyranosyl-substituted benzene derivatives, drug containing these compounds, their use and methods for their preparation | |
DK1833799T3 (en) | 3-Phenyl-pyrazole derivatives as modulators of 5-HT-2α-serotonin receptor useful for the treatment of diseases related thereto | |
DK1758914T3 (en) | New Fluoroglycoside Derivatives of Pyrazoles, Drugs Containing These Compounds, and Uses thereof | |
NO20050134D0 (en) | Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use | |
DK1620429T3 (en) | New heterocyclic compounds useful in the treatment of inflammatory and allergic diseases, methods of their preparation and pharmaceutical compositions containing them | |
NO20054006D0 (en) | Cyclic urea derivatives, their preparation process and the pharmaceutical use of the same as kinase inhibitors | |
NO20040356L (en) | Indanacetic acid derivatives and their use as pharmaceutical agents, intermediates and methods of preparation. | |
DK1708992T3 (en) | Sulfonamide derivatives for the treatment of diseases | |
NO20081001L (en) | Derivatives of carboxamide as antagonists of muscarinic receptor | |
DK1701946T3 (en) | 1-piperazine and 1-homopiperazine carboxylate derivatives, their preparation and their therapeutic use as inhibitors of the FAAH enzyme | |
NO20042155L (en) | N-adamantylmethyl derivatives and intermediates such as pharmaceutical compositions and processes for their preparation | |
NO20062021L (en) | Redirected pentanols, their methods of preparation, and their use as antiflogistics | |
DK1651644T3 (en) | Substituted derivatives of thiazole-benzoisothiazole dioxide, process thereof and their use | |
NO20052262D0 (en) | Process for Preparation of 4-Substituted 2,2,6,6-Tetramethyl-Piperidine-N-Oxy and 2,2,6,6-Tetramethyl-Piperidine-N-Hydroxy Compounds | |
DK1601363T3 (en) | Use as a drug of cholest-4-one-3-one derivatives, pharmaceutical compositions containing them and novel derivatives | |
DK1879580T3 (en) | 4-Phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as drugs for the treatment of infertility | |
DK1667967T3 (en) | Process for the preparation of 2-oxo-1-pyrrolidine derivatives | |
DK1838683T3 (en) | Process for the preparation of [1,4,5] oxadiazepine derivatives |